Cart
sales@molnova.com
IQDMA
CAS No. 401463-02-3
IQDMA( C524250 | IQDMA cpd | IQDMA )
Catalog No. M14373 CAS No. 401463-02-3
A cell-permeable, small molecule inhibitor of the transcription factor STAT5.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIQDMA
-
NoteResearch use only, not for human use.
-
Brief DescriptionA cell-permeable, small molecule inhibitor of the transcription factor STAT5.
-
DescriptionA cell-permeable, small molecule inhibitor of the transcription factor STAT5 that exhibits anticancer activity and inhibits the growth of A549, HL-60 and K562 cells with IC50 of 8, 5 and 8 uM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsC524250 | IQDMA cpd | IQDMA
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number401463-02-3
-
Formula Weight304.397
-
Molecular FormulaC19H20N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)CCNC1=NC2=CC=CC=C2C3=C1C4=C(N3)C=CC=C4
-
Chemical NameN'-(11H-indolo[3,2-c]quinolin-6-yl)-N,N-dimethylethane-1,2-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu XW, et al. Cell Biol Toxicol. 2006 Nov;22(6):417-27.
2. Chien CM, et al. Chem Biol Interact. 2008 Oct 22;176(1):40-7.
3. Hodge LS, et al. Blood. 2014 Feb 13;123(7):1055-8.
molnova catalog
related products
-
BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
STAT3-IN-1
STAT3-IN-1 selective and orally active inhibitor of STAT3(in HT29 and MDA-MB 231 cells, with IC50 values of 1.82 μM and 2.14 μM , respectively), induces tumor apoptosis.
-
Nifuroxazide
Nifuroxazide is a cell-permeable and orally available nitrofuran-based antidiarrheal agent that effectively suppresses the activation of cellular STAT1/3/5 transcription activity .
